Continuation therapy in endogenous depression controlled by changes in the TRH stimulation test
- 1 August 1978
- journal article
- research article
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 8 (3), 501-503
- https://doi.org/10.1017/s0033291700016202
Abstract
Synopsis Thyrotropin response to thyrotropin-releasing hormone is impaired during endogenous depression and normalized between the depressive periods. Changes in the thyrotropin response to thyrotropin-releasing hormone were shown to be of predictive value and might be useful in the control of continuation therapy with antidepressants in patients with endogenous depression.Keywords
This publication has 12 references indexed in Scilit:
- Studies on the influence of biogenic amines and psychoactive drugs on the prognostic value of the TRH stimulation test in endogenous depressionPsychoneuroendocrinology, 1977
- Prophylaxis of Affective DisordersArchives of General Psychiatry, 1976
- Overview: maintenance therapy in psychiatry: II. Affective disordersAmerican Journal of Psychiatry, 1976
- PROGNOSTIC VALUE OF THYROTROPIN- RELEASING HORMONE STIMULATION TEST IN ENDOGENOUS DEPRESSIONActa Psychiatrica Scandinavica, 1975
- Lithium Carbonate and Imipramine in Prevention of Affective EpisodesArchives of General Psychiatry, 1973
- EFFECTS OF THYROTROPIN-RELEASING HORMONE IN DEPRESSION*1The Lancet, 1972
- IMPROVEMENT IN MENTAL DEPRESSION WITH DECREASED THYROTROPIN RESPONSE AFTER ADMINISTRATION OF THYROTROPIN-RELEASING HORMONEThe Lancet, 1972
- CONTINUATION THERAPY WITH TRICYCLIC ANTIDEPRESSANTS IN DEPRESSIVE ILLNESSThe Lancet, 1972
- A Seven-Month Double-Blind Trial of Amitriptyline and Diazepam in ECT-Treated Depressed PatientsThe British Journal of Psychiatry, 1970
- Imipramine with electrical treatment in depression—A controlled trialJournal of Mental Science, 1962